146 related articles for article (PubMed ID: 33371844)
1. Molecular Docking and Pharmacoinformatics Studies Reveal Potential Phytochemicals Against HCV NS5B Polymerase.
Khalid H; Ashfaq UA
Comb Chem High Throughput Screen; 2022; 25(2):335-346. PubMed ID: 33371844
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of Taraxacum officinale against HCV NS5B polymerase: In-vitro and In silico study.
Rehman S; Ijaz B; Fatima N; Muhammad SA; Riazuddin S
Biomed Pharmacother; 2016 Oct; 83():881-891. PubMed ID: 27513212
[TBL] [Abstract][Full Text] [Related]
3. Screening and molecular docking of selected phytochemicals against NS5B polymerase of hepatitis c virus.
Mustafa G; Majid M; Ghaffar A; Yameen M; Samad HA; Mahrosh HS
Pak J Pharm Sci; 2020 Sep; 33(5(Supplementary)):2317-2322. PubMed ID: 33832906
[TBL] [Abstract][Full Text] [Related]
4. Pharmacoinformatics approach for investigation of alternative potential hepatitis C virus nonstructural protein 5B inhibitors.
Mirza MU; Ghori NU; Ikram N; Adil AR; Manzoor S
Drug Des Devel Ther; 2015; 9():1825-41. PubMed ID: 25848219
[TBL] [Abstract][Full Text] [Related]
5. Repositioning of RdRp Inhibitors Against HCV NS5B Polymerase Utilizing Structure-Based Molecular Docking.
Tarannum H; Nandi S
Comb Chem High Throughput Screen; 2022; 25(4):702-719. PubMed ID: 33475069
[TBL] [Abstract][Full Text] [Related]
6. The Life Cycle and in silico Elucidation of Non-structural Replicating Proteins of HCV Through a Pharmacoinformatics Approach.
Tahir RA; Mughal S; Nazir A; Noureen A; Jawad A; Waqas M; Sehgal SA
Comb Chem High Throughput Screen; 2022; 25(4):689-701. PubMed ID: 33596796
[TBL] [Abstract][Full Text] [Related]
7. Novel Guanosine Derivatives as Anti-HCV NS5b Polymerase: A QSAR and Molecular Docking Study.
Elfiky AA
Med Chem; 2019; 15(2):130-137. PubMed ID: 30324891
[TBL] [Abstract][Full Text] [Related]
8.
Brice Landry K; Tariq S; Malik A; Sufyan M; Ashfaq UA; Ijaz B; Shahid AA
J Biomol Struct Dyn; 2022 Oct; 40(17):7829-7851. PubMed ID: 33764266
[No Abstract] [Full Text] [Related]
9. Structural insights into NS5B protein of novel equine hepaciviruses and pegiviruses complexed with polymerase inhibitors.
de Albuquerque PPLF; Santos LHS; Antunes D; Caffarena ER; Figueiredo AS
Virus Res; 2020 Mar; 278():197867. PubMed ID: 31972246
[TBL] [Abstract][Full Text] [Related]
10. Multiple e-pharmacophore modeling, 3D-QSAR, and high-throughput virtual screening of hepatitis C virus NS5B polymerase inhibitors.
Therese PJ; Manvar D; Kondepudi S; Battu MB; Sriram D; Basu A; Yogeeswari P; Kaushik-Basu N
J Chem Inf Model; 2014 Feb; 54(2):539-52. PubMed ID: 24460140
[TBL] [Abstract][Full Text] [Related]
11. Identification of potential anti-hepatitis C virus agents targeting non structural protein 5B using computational techniques.
Polamreddy P; Vishwakarma V; Saxena P
J Cell Biochem; 2018 Nov; 119(10):8574-8587. PubMed ID: 30058078
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Novel Hepatitis C Virus NS5B Polymerase Inhibitors by Combining Random Forest, Multiple e-Pharmacophore Modeling and Docking.
Wei Y; Li J; Qing J; Huang M; Wu M; Gao F; Li D; Hong Z; Kong L; Huang W; Lin J
PLoS One; 2016; 11(2):e0148181. PubMed ID: 26845440
[TBL] [Abstract][Full Text] [Related]
13. Screening of hepatitis C NS5B polymerase inhibitors containing benzothiadiazine core: a steered molecular dynamics.
Nutho B; Meeprasert A; Chulapa M; Kungwan N; Rungrotmongkol T
J Biomol Struct Dyn; 2017 Jun; 35(8):1743-1757. PubMed ID: 27236925
[TBL] [Abstract][Full Text] [Related]
14. Probing the "fingers" domain binding pocket of Hepatitis C virus NS5B RdRp and D559G resistance mutation via molecular docking, molecular dynamics simulation and binding free energy calculations.
Manjula S; Sivanandam M; Kumaradhas P
J Biomol Struct Dyn; 2019 Jun; 37(9):2440-2456. PubMed ID: 30047829
[TBL] [Abstract][Full Text] [Related]
15. Slow binding inhibition and mechanism of resistance of non-nucleoside polymerase inhibitors of hepatitis C virus.
Hang JQ; Yang Y; Harris SF; Leveque V; Whittington HJ; Rajyaguru S; Ao-Ieong G; McCown MF; Wong A; Giannetti AM; Le Pogam S; Talamás F; Cammack N; Nájera I; Klumpp K
J Biol Chem; 2009 Jun; 284(23):15517-29. PubMed ID: 19246450
[TBL] [Abstract][Full Text] [Related]
16. Discovery of hit molecules targeting allosteric site of hepatitis C virus NS5B polymerase.
Polamreddy P; Vishwakarma V; Arumugam P; Bheemanati R; Esram P; Mahto MK; Kacker P
J Biomol Struct Dyn; 2020 Mar; 38(5):1448-1466. PubMed ID: 31007134
[TBL] [Abstract][Full Text] [Related]
17. Accounting for target flexibility and water molecules by docking to ensembles of target structures: the HCV NS5B palm site I inhibitors case study.
Barreca ML; Iraci N; Manfroni G; Gaetani R; Guercini C; Sabatini S; Tabarrini O; Cecchetti V
J Chem Inf Model; 2014 Feb; 54(2):481-97. PubMed ID: 23952658
[TBL] [Abstract][Full Text] [Related]
18. Antiviral phytochemicals identification from Azadirachta indica leaves against HCV NS3 protease: an in silico approach.
Ashfaq UA; Jalil A; Ul Qamar MT
Nat Prod Res; 2016 Aug; 30(16):1866-9. PubMed ID: 26274064
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel natural flavonoids as potent antiviral candidates against hepatitis C virus NS5B polymerase.
Akher FB; Farrokhzadeh A; Ramharack P; Shunmugam L; Van Heerden FR; Soliman MES
Med Hypotheses; 2019 Nov; 132():109359. PubMed ID: 31466018
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies.
Yeung KS; Beno BR; Parcella K; Bender JA; Grant-Young KA; Nickel A; Gunaga P; Anjanappa P; Bora RO; Selvakumar K; Rigat K; Wang YK; Liu M; Lemm J; Mosure K; Sheriff S; Wan C; Witmer M; Kish K; Hanumegowda U; Zhuo X; Shu YZ; Parker D; Haskell R; Ng A; Gao Q; Colston E; Raybon J; Grasela DM; Santone K; Gao M; Meanwell NA; Sinz M; Soars MG; Knipe JO; Roberts SB; Kadow JF
J Med Chem; 2017 May; 60(10):4369-4385. PubMed ID: 28430437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
